Indian Regulatory Support for Orphan Drugs: CDSCO and NDCTR Framework
Indian Regulatory Support for Orphan Drugs: CDSCO and NDCTR Framework How India Supports Orphan Drugs and Rare Disease Trials through Regulatory Innovation Introduction Orphan drugs play a vital role in addressing unmet medical needs in rare disease populations, often comprising less than 1 in 10,000 individuals. With over 7,000 known rare diseases globally and more…
Read More “Indian Regulatory Support for Orphan Drugs: CDSCO and NDCTR Framework” »